共 50 条
- [31] Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS). JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
- [33] Localized, high-risk soft tissue sarcomas (STS) of the extremities and trunk wall in adults: Three versus five cycles of full-dose anthracyclin and ifosfamide adjuvant chemotherapy: A phase III randomized trial from the Italian Sarcoma Group (ISG) and Spanish Sarcoma Group (GEIS) JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
- [37] Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients:: results of a randomised study comparing high-dose chemotherapy followed by autologous stem cell transplantation with standard-dose chemotherapy BONE MARROW TRANSPLANTATION, 2005, 35 : S2 - S3
- [39] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG). JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)